Company Overview of Intralytix, Inc.
Intralytix, Inc., a biotechnology company, engages in the production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings. It offers various food safety products that target listeria monocytogenes, escherichia coli, and pathogenic salmonella-serotypes contaminations in foods and food processing facilities. The company also provides probiotic/nutraceutical products, including ShigActive, which targets shigella species in the gastrointestinal tract. In addition, it develops and licenses animal health products, including INT-401, which targets clostridium perfringens in live poultry; and PLSV-1 that provides protect...
The Columbus Center
701 East Pratt Street
Baltimore, MD 21202
Founded in 1998
Key Executives for Intralytix, Inc.
Compensation as of Fiscal Year 2014.
Intralytix, Inc. Key Developments
Intralytix, Inc. Wins Regulatory Approval For Phage-Based Food Safety Product Effective Against Salmonella
Feb 28 13
Intralytix, Inc. has received GRAS (Generally Recognized As Safe) recognition from the Food and Drug Administration (FDA). SalmoFresh is an antimicrobial preparation for controlling the foodborne bacterial pathogen Salmonella enterica. The active ingredients of SalmoFresh are naturally occurring lytic bacteriophages that selectively and specifically kill Salmonella, including strains belonging to the most common /highly pathogenic serotypes: Typhimurium, Enteritidis, Heidelberg, Newport, Hadar, Kentucky, and Thompson. SalmoFresh is specifically designed for treating foods that are at high risk for Salmonella contamination. Red meat and poultry in particular can be treated prior to grinding for significant reductions in Salmonella contamination. SalmoFresh is all natural, kosher and halal.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries